ArticleRheumatology and therapy2023

Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial.

Mikkel Østergaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.